Olympus Corp.

OCPNF

$9.49May 03, 2021Apr 29, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$9.48B
MVM
+$0.0M
PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Chart Start
$20.50
2021
Since 2021
-53.7%
vs SPY +70.2%
All-time High
$24.83 · Aug 2022
-61.8% from peak
MVM Rank
#96 of 192
Health Care Equipment
Reaction Win Rate
11%
2 of 19 events

Olympus Corp. has returned -53.7% from $20.50 since 2021, trailing SPY's +70.2% over the same period. The stock hit an all-time high of $24.83 in Aug 2022 and is currently 61.8% below that level. Of 19 tracked news events, 11% produced a positive market-adjusted return.

How to use this page
1Company Research Snapshot

Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.

2Company Q&A

Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.

3News & Events

Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.

Show ▼
Company Q&AShow ▼
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-02-17-19.9%newsGlobeNewswireDisposable Endoscope Analysis Report 2025: A $4.95 Billion Market by 2029 - Aging Population and Growing Healthcare Expenditure Accelerate Shift Toward Disposable Endoscopic Solutions
2023-08-09-17.4%earningsSeeking AlphaOlympus Corporation 2024 Q1 - Results - Earnings Call Presentation
2023-05-12-7.4%earningsSeeking AlphaOlympus GAAP EPS of 113.08, revenue of 881.92B
2023-02-10-4.2%earningsSeeking AlphaOlympus Corporation (OCPNF) Q3 2023 Earnings Call Transcript
2023-02-10-4.2%earningsSeeking AlphaOlympus GAAP EPS of 85.04, revenue of 641.55B
2023-09-08-4.0%legalSeeking AlphaOlympus: Experiencing Slower Growth, Cost Overruns And FDA Scrutiny
2024-08-09-3.4%earningsSeeking AlphaOlympus Corporation 2025 Q1 - Results - Earnings Call Presentation
2025-08-09-3.1%earningsSeeking AlphaOlympus Corporation 2026 Q1 - Results - Earnings Call Presentation
2023-11-10-1.5%earningsSeeking AlphaOlympus Corporation 2024 Q2 - Results - Earnings Call Presentation
2023-08-11-1.4%earningsSeeking AlphaOlympus Corporation (OCPNF) Q1 2024 Earnings Call Transcript
2023-08-11-1.4%earningsSeeking AlphaOlympus GAAP EPS of 191.50, revenue of 207.72B
2023-01-12-0.9%legalSeeking AlphaOlympus says addressing FDA concerns on endoscope production
2025-05-13-0.8%earningsSeeking AlphaOlympus Corporation 2025 Q4 - Results - Earnings Call Presentation
2026-02-19+0.6%earningsSeeking AlphaOlympus Corporation 2026 Q3 - Results - Earnings Call Presentation
2022-11-12-0.6%earningsSeeking AlphaOlympus Corporation 2022 Q3 - Results - Earnings Call Presentation
2024-12-21-0.6%newsStockInvest.usOlympus Corp. Stock Data and Signals - OCPNF - StockInvest.us
2025-02-14-0.3%earningsSeeking AlphaOlympus outlines GI and surgical division reorganization with FY 2025 revenue forecast at 997.5B
2025-02-14-0.3%earningsSeeking AlphaOlympus reports Q3 results
2023-11-11+0.1%earningsSeeking AlphaOlympus Corporation (OCPNF) Q2 2024 Earnings Call Transcript
tickerdossier.comtickerdossier.substack.com